Mercury Biopharmaceutical Corporation

Mercury Biopharmaceutical Corporationverified

6932.TWO

Price:

$12.7

Market Cap:

$5.31B

Mercury Biopharmaceutical Corporation engages in the development of drugs for unmet needs in Taiwan. The company develops StackDose platform, a drug development platform to produce new dosage forms with precise time-controlled dissolution, precise site absorption, and various dosage adjustments to enhance the bio-availability of active pharmaceutical ingredients to reduce the dosage of drugs and its side effects. It develops drugs for treating erectile dysfunction, pulmonary hypertension, sleep disorder, benign prostatic hyperplasia, angina pectoris, migraine, anti-hypertension, and analgesic. The company was founded in 2019 and is based in New Taipei City, Taiwan.

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2022-12-23

Stock Exchange

TWO

Ticker

6932.TWO

The PE Ratio as of May 2025 (TTM) for Mercury Biopharmaceutical Corporation (6932.TWO) is -105.83

According to Mercury Biopharmaceutical Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -105.83. This represents a change of 20.45% compared to the average of -87.86 of the last 4 quarters.

Mercury Biopharmaceutical Corporation (6932.TWO) Historical PE Ratio (quarterly & annually)

How has 6932.TWO PE Ratio performed in the past?

The mean historical PE Ratio of Mercury Biopharmaceutical Corporation over the last ten years is -1166.25. The current -105.83 PE Ratio has changed 807.44% with respect to the historical average. Over the past ten years (40 quarters), 6932.TWO's PE Ratio was at its highest in in the June 2019 quarter at 0. The PE Ratio was at its lowest in in the June 2020 quarter at -2984.93.

Quarterly (TTM)
Annual

Average

-1166.25

Median

-146.15

Minimum

-5969.87

Maximum

0

Mercury Biopharmaceutical Corporation (6932.TWO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Mercury Biopharmaceutical Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 42.63%

Maximum Annual PE Ratio = 0

Minimum Annual Increase = -Infinity%

Minimum Annual PE Ratio = -5969.87

Quarterly (TTM)
Annual
YearPE RatioChange
2024-107.35-37.52%
2023-171.8242.63%
2022-120.47-80.82%
2021-628.00-89.48%
2020-5969.87-Infinity%

Mercury Biopharmaceutical Corporation (6932.TWO) Average PE Ratio

How has 6932.TWO PE Ratio performed in the past?

The current PE Ratio of Mercury Biopharmaceutical Corporation (6932.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-133.21

5-year avg

-1399.50

10-year avg

-1166.25

Mercury Biopharmaceutical Corporation (6932.TWO) PE Ratio vs. Peers

How is 6932.TWO’s PE Ratio compared to its peers?

Mercury Biopharmaceutical Corporation’s PE Ratio is

CompanyPE RatioMarket cap

Build a custom stock screener for Mercury Biopharmaceutical Corporation (6932.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mercury Biopharmaceutical Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mercury Biopharmaceutical Corporation (6932.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mercury Biopharmaceutical Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Mercury Biopharmaceutical Corporation's PE Ratio?

How is the PE Ratio calculated for Mercury Biopharmaceutical Corporation (6932.TWO)?

What is the highest PE Ratio for Mercury Biopharmaceutical Corporation (6932.TWO)?

What is the 3-year average PE Ratio for Mercury Biopharmaceutical Corporation (6932.TWO)?

What is the 5-year average PE Ratio for Mercury Biopharmaceutical Corporation (6932.TWO)?

How does the current PE Ratio for Mercury Biopharmaceutical Corporation (6932.TWO) compare to its historical average?